
Dileep Kumar Raveendran Nair
About Dileep Kumar Raveendran Nair
Data last updated:
Dileep Kumar Raveendran Nair has 9 years in corporate governance. Holds Director role. Currently with 5 companies, including Edgeai Private Limited and D2sbiosolutions Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 May 2017 | 2017 | – | Active | |
| Director | 11 Jun 2024 | 2024 | – | Active | |
| Director | 11 Apr 2024 | 2024 | – | Active | |
| Director | 19 Jul 2022 | 2022 | – | Active | |
| Director | 23 Jul 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dileep Kumar Raveendran Nair
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dileep Kumar Raveendran Nair
Dileep Kumar Raveendran Nair has 9 years in corporate governance. Holds Director role. Currently with 5 companies, including Edgeai Private Limited and D2sbiosolutions Private Limited. Engaged in General Business. Contributes to corporate operations.
Dileep Kumar Raveendran Nair is associated with 5 companies as Director, including Indriyam Biologics Private Limited, Breathelife Biosciences Private Limited, Scinova Solutions Private Limited.
Dileep Kumar Raveendran Nair has expertise in General Business.
Dileep Kumar Raveendran Nair has 9 years in corporate governance.
Dileep Kumar Raveendran Nair currently holds positions at 5 companies: Indriyam Biologics Private Limited, Breathelife Biosciences Private Limited, Scinova Solutions Private Limited, D2sbiosolutions Private Limited, Edgeai Private Limited.